ATE556084T1 - Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c - Google Patents

Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c

Info

Publication number
ATE556084T1
ATE556084T1 AT08000552T AT08000552T ATE556084T1 AT E556084 T1 ATE556084 T1 AT E556084T1 AT 08000552 T AT08000552 T AT 08000552T AT 08000552 T AT08000552 T AT 08000552T AT E556084 T1 ATE556084 T1 AT E556084T1
Authority
AT
Austria
Prior art keywords
compositions
methods
hepatitis
characterizing
identifying
Prior art date
Application number
AT08000552T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of ATE556084T1 publication Critical patent/ATE556084T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT08000552T 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c ATE556084T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11

Publications (1)

Publication Number Publication Date
ATE556084T1 true ATE556084T1 (de) 2012-05-15

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
AT03714097T ATE423785T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c
AT08000552T ATE556084T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
AT08014584T ATE469162T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03714097T ATE423785T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08014584T ATE469162T1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c

Country Status (9)

Country Link
US (3) US20070172926A1 (de)
EP (3) EP2014671B1 (de)
AT (3) ATE423785T1 (de)
AU (2) AU2003218111B8 (de)
DE (2) DE60326327D1 (de)
DK (3) DK1947104T3 (de)
ES (3) ES2321498T3 (de)
PT (3) PT1490383E (de)
WO (1) WO2003077729A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2014671B1 (de) 2002-03-11 2010-05-26 Lab 21 Limited Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C
US20090081636A1 (en) * 2005-04-11 2009-03-26 Mingjun Huang Pharmaceutical compositions for and methods of inhibiting HCV replication
JP2009512426A (ja) * 2005-10-14 2009-03-26 イヴァン・ペテャエフ 偏性細胞内病原体の治療および診断
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
US20080015787A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20080015834A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
EP2463389A1 (de) 2006-10-20 2012-06-13 Innogenetics N.V. Methodik zur Analyse von Sequenzvariationen innerhalb des HCV-NS5B-Genombereichs
WO2008046923A2 (en) * 2006-10-20 2008-04-24 Innogenetics N.V. Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
CN101842498A (zh) * 2007-10-30 2010-09-22 英特芒尼公司 Hcv基因型分型和表型分型
US8911934B2 (en) * 2007-10-31 2014-12-16 Debiopharm Sa Near full-genome assay of HCV drug resistance
WO2011151405A1 (en) 2010-06-04 2011-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
US9528163B2 (en) 2011-06-20 2016-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting HCV
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NZ227011A (en) 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (de) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNS-Gen von einem Non-A Non-B Hepatitis-Virus, seine Klonierung und Verwendung
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
US7157226B1 (en) * 1993-04-27 2007-01-02 Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
AU695259B2 (en) * 1993-05-05 1998-08-13 Common Services Agency Hepatitis-C virus type 4, 5 and 6
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
AU8897698A (en) * 1997-07-30 1999-02-22 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
US20040137436A1 (en) * 2000-04-18 2004-07-15 Brendan Larder Method for measuring drug resistance
EP1296998B1 (de) * 2000-05-23 2011-09-21 Washington University Varianten des hepatitisvirus
WO2002008447A2 (en) * 2000-07-24 2002-01-31 Institute Of Molecular & Cell Biology Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
EP2014671B1 (de) 2002-03-11 2010-05-26 Lab 21 Limited Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C

Also Published As

Publication number Publication date
EP1490383A4 (de) 2005-12-21
AU2003218111A1 (en) 2003-09-29
AU2008249300A1 (en) 2008-12-18
PT1947104E (pt) 2012-08-09
WO2003077729A9 (en) 2004-04-22
AU2008249300B2 (en) 2012-08-16
EP2014671A1 (de) 2009-01-14
EP1947104A3 (de) 2009-04-08
WO2003077729A2 (en) 2003-09-25
PT2014671E (pt) 2010-06-16
US20090047663A1 (en) 2009-02-19
EP1490383A2 (de) 2004-12-29
DK1490383T3 (da) 2009-06-08
DE60326327D1 (de) 2009-04-09
ES2346717T3 (es) 2010-10-19
AU2003218111B8 (en) 2008-11-20
EP1490383B1 (de) 2009-02-25
ES2321498T3 (es) 2009-06-08
DE60332781D1 (de) 2010-07-08
WO2003077729A3 (en) 2004-06-03
US8173795B2 (en) 2012-05-08
US20120322051A1 (en) 2012-12-20
ES2386742T3 (es) 2012-08-28
US20070172926A1 (en) 2007-07-26
EP1947104A2 (de) 2008-07-23
ATE423785T1 (de) 2009-03-15
ATE469162T1 (de) 2010-06-15
DK2014671T3 (da) 2010-09-20
EP1947104B1 (de) 2012-05-02
PT1490383E (pt) 2009-05-25
DK1947104T3 (da) 2012-08-06
EP2014671B1 (de) 2010-05-26
AU2003218111B2 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
ATE469162T1 (de) Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
ATE397092T1 (de) Methode zur direkten sequenzierung von nukleinsäuren
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
ATE428003T1 (de) Oligonukleotidprimer zur effizienten detektion von hepatitis c virus (hcv) sowie verwendungsverfahren
DE69433487D1 (de) Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung
ATE364718T1 (de) Verfahren zur vervielfältigung von nukleinsäure
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE485391T1 (de) Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE60324819D1 (de) Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus
DE60024679D1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
DE59912683D1 (de) Verfahren und Zusammensetzungen zur Isolierung und Reinigung von Nukleinsäuren
ATE328117T1 (de) Verfahren und sonden zur genetischen diagnose von heriditärer hämochromatose
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis
DE602006005932D1 (de) Verfahren zur identifizierung von proteinfaltungsinhibitoren